(1R,2S)-2-(phenylmethoxymethyl)cyclopent-3-en-1-ol

We are (1R,2S)-2-(phenylmethoxymethyl)cyclopent-3-en-1-ol CAS:188399-48-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(1R,2S)-2-(phenylmethoxymethyl)cyclopent-3-en-1-ol
CAS.NO:188399-48-6
Synonyms:(1R,2S)-2-(phenylmethoxymethyl)cyclopent-3-en-1-ol
(1S,2R)-2-((benzyloxy)methyl)cyclopent-3-enol
(1R,2S)-2-(benzyloxymethyl)cyclopent-3-en-1-ol
(1SR,2S)-2-((benzyloxy)methyl)cyclopent-3-enol
(1R,2S)-2-(benzyloxymethyl)cyclopent-3-enol
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 318.9±22.0 °C at 760 mmHg
Molecular Formula C13H16O2
Molecular Weight 204.265
Flash Point 135.5±16.6 °C
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Entecavir(CAS:142217-69-4).

(1R,2S)-2-(phenylmethoxymethyl)cyclopent-3-en-1-ol


Related News: The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.Sulfato de 2,6-diaminopiridina CAS:146997-97-9 This includes chemical APIs.4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-N-methylsufonyl)amino]pyrimidine-5-yl-methanol CAS:147118-36-3 Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.2-Chloro-4-fluorobenzaldehyde CAS:84194-36-5 At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.

Related Products
Product Name
Chloral hydrate View Details
2,3,5-Trimethylpyrazine View Details
1-AMINO-1-CYCLOPENTANECARBOXAMIDE View Details
Pyridoxine manufacturer 2-Aminosulfonyl-N,N-Dimethylnicotinamide manufacturer 3-Bromophenylboronic acid manufacturer 5-(2-ethylsulfanylpropyl)cyclohexane-1,3-dione manufacturer 2,3,4,5,6-Pentafluorostyrene manufacturer